T Takei
Overview
Explore the profile of T Takei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
361
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takei T, Koyama F, Iwasa Y, Kuge H, Sho M
Tech Coloproctol
. 2022 Mar;
26(7):595-596.
PMID: 35275287
No abstract available.
2.
Maya Y, Fujita Y, Mizukami T, Takei T, Shimizu S
J Eur Acad Dermatol Venereol
. 2020 Oct;
35(4):e261-e263.
PMID: 33040411
No abstract available.
3.
Shiba K, Takei T, Yoshikawa G, Ogawa M
Nanoscale
. 2017 Oct;
9(43):16791-16799.
PMID: 29072757
A titania-stearic acid hybrid layer was deposited onto well-defined silica-hexadecyltrimethylammonium hybrid spherical particles with 854 nm size to obtain nanoporous particles with a useful hierarchical core-shell structure. The deposition of...
4.
Shiba K, Sugiyama T, Takei T, Yoshikawa G
Chem Commun (Camb)
. 2015 Sep;
51(87):15854-7.
PMID: 26376831
Silica/titania-based functional nanoparticles were prepared through controlled nucleation of titania and subsequent encapsulation by silica through a multistep microfluidic approach, which was successfully applied to obtaining aminopropyl-functionalized silica/titania nanoparticles for...
5.
Takei T, Nakahara H, Ijima H, Kawakami K
Acta Biomater
. 2011 Oct;
8(2):686-93.
PMID: 22023751
Conventional chitosan hydrogels exhibit an acidic nature and contain unfavorable additives because (i) chitosan is soluble only in acidic solutions and (ii) toxic chemicals or proteins of non-human origin that...
6.
Smirnova O, Kumada N, Takei T, Yonesaki Y, Yashima M, Kinomura N
Acta Crystallogr B
. 2010 Nov;
66(Pt 6):594-602.
PMID: 21099022
Single-crystal, synchrotron powder X-ray diffraction and neutron powder diffraction studies of the novel pyrochlore-type compound with the structural formula K(0.88)(OH)(0.54)H(1.66)(H(2)O)(1.04)Nb(2)O(6) suggests that the water molecules are located in 32e sites,...
7.
Takei T, Matsuoka S, Ashitani N, Makihara N, Morizane M, Ohara N
Clin Exp Obstet Gynecol
. 2009 Aug;
36(2):130-2.
PMID: 19688960
Cornual pregnancy is uncommon among ectopic pregnancies. A diagnosis of cornual pregnancy remains challenging, and rupture of a cornual pregnancy causes catastrophic consequence due to massive bleeding. We report a...
8.
Sawara Y, Itabashi M, Kojima C, Tabata H, Kamei D, Kawanishi K, et al.
Clin Nephrol
. 2009 Jul;
72(1):69-72.
PMID: 19640390
Minimal change nephrotic syndrome (MCNS) usually is considered to have a good renal prognosis, but the frequency of relapses is a therapeutic challenge to physicians. The treatment of patients with...
9.
Prasad G, Kumada N, Yamanaka J, Yonesaki Y, Takei T, Kinomura N
J Colloid Interface Sci
. 2005 Dec;
297(2):654-9.
PMID: 16364352
Novel lamellar nanocomposites composed of exfoliated SbP2O8- nanosheets and poly(N-methyl-2-ethynyl pyridinium iodide) (PNMe) or poly(N-octadecyl-2-ethynyl pyridinium bromide) (PNO) have been synthesized by exfoliation and re-stacking method. The XRD data of...
10.
Yumura W, Suganuma S, Uchida K, Moriyama T, Otsubo S, Takei T, et al.
Clin Nephrol
. 2005 Jul;
64(1):28-34.
PMID: 16047642
Aim: Mizoribine (MZR) is a purine antimetabolic immunosuppressant agent that has few little severe adverse events. We studied whether maintenance therapy with MZR and prednisolone (PSL) in severe proliferative lupus...